Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 132 citing articles:

Oxidative Stress, Synaptic Dysfunction, and Alzheimer’s Disease
Eric Tönnies, Eugenia Trushina
Journal of Alzheimer s Disease (2017) Vol. 57, Iss. 4, pp. 1105-1121
Open Access | Times Cited: 1442
Mitochondria as a therapeutic target for common pathologies
Michael P. Murphy, Richard C. Hartley
Nature Reviews Drug Discovery (2018) Vol. 17, Iss. 12, pp. 865-886
Closed Access | Times Cited: 644
Formation and Biological Targets of Quinones: Cytotoxic versus Cytoprotective Effects
Judy L. Bolton, Tareisha L. Dunlap
Chemical Research in Toxicology (2016) Vol. 30, Iss. 1, pp. 13-37
Open Access | Times Cited: 368
Comprehensive review of mechanisms of pathogenesis involved in Alzheimer’s disease and potential therapeutic strategies
Piyoosh Sharma, Pavan Srivastava, Ankit Seth, et al.
Progress in Neurobiology (2018) Vol. 174, pp. 53-89
Closed Access | Times Cited: 285
Involvement of Lipids in Alzheimer’s Disease Pathology and Potential Therapies
Hannah Chew, Victoria Solomon, Alfred N. Fonteh
Frontiers in Physiology (2020) Vol. 11
Open Access | Times Cited: 263
Pathological mechanisms and therapeutic strategies for Alzheimer’s disease
Kin Yip Tam, Yaojun Ju
Neural Regeneration Research (2021) Vol. 17, Iss. 3, pp. 543-543
Open Access | Times Cited: 251
Ultrasound-assisted extraction of natural antioxidants from the flower of Limonium sinuatum: Optimization and comparison with conventional methods
Dong-ping Xu, Jie Zheng, Yue Zhou, et al.
Food Chemistry (2016) Vol. 217, pp. 552-559
Closed Access | Times Cited: 227
Diabetes and Alzheimer’s disease crosstalk
David Baglietto‐Vargas, Jessica J. Shi, Devin M. Yaeger, et al.
Neuroscience & Biobehavioral Reviews (2016) Vol. 64, pp. 272-287
Closed Access | Times Cited: 213
Primary Mitochondrial Disease and Secondary Mitochondrial Dysfunction: Importance of Distinction for Diagnosis and Treatment
Dmitriy M. Niyazov, Stephan G. Kahler, Richard E. Frye
Molecular Syndromology (2016) Vol. 7, Iss. 3, pp. 122-137
Open Access | Times Cited: 198
Mitochondrial dynamics and transport in Alzheimer's disease
Padraig J. Flannery, Eugenia Trushina
Molecular and Cellular Neuroscience (2019) Vol. 98, pp. 109-120
Open Access | Times Cited: 161
Metabolic Dysregulation Contributes to the Progression of Alzheimer’s Disease
Xu Yan, Yue Hu, Biyao Wang, et al.
Frontiers in Neuroscience (2020) Vol. 14
Open Access | Times Cited: 146
Metabolism: A Novel Shared Link between Diabetes Mellitus and Alzheimer’s Disease
Yanan Sun, Cao Ma, Hui Sun, et al.
Journal of Diabetes Research (2020) Vol. 2020, pp. 1-12
Open Access | Times Cited: 139
Antioxidant Therapy in Oxidative Stress-Induced Neurodegenerative Diseases: Role of Nanoparticle-Based Drug Delivery Systems in Clinical Translation
Anushruti Ashok, Syed Suhail Andrabi, Saffar Mansoor, et al.
Antioxidants (2022) Vol. 11, Iss. 2, pp. 408-408
Open Access | Times Cited: 122
Mitochondria-Targeted Antioxidants, an Innovative Class of Antioxidant Compounds for Neurodegenerative Diseases: Perspectives and Limitations
Matteo Fields, Annalisa Marcuzzi, Arianna Gonelli, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3739-3739
Open Access | Times Cited: 44
The mitochondrial permeability transition pore in AD 2016: An update
Lucia Biasutto, Michele Azzolini, Ildikò Szabó, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (2016) Vol. 1863, Iss. 10, pp. 2515-2530
Closed Access | Times Cited: 120
Ethnopharmacological Approaches for Dementia Therapy and Significance of Natural Products and Herbal Drugs
Devesh Tewari, Adrian Stankiewicz, Andrei Mocan, et al.
Frontiers in Aging Neuroscience (2018) Vol. 10
Open Access | Times Cited: 119
Mitochondrial Potentiation Ameliorates Age-Related Heterogeneity in Hematopoietic Stem Cell Function
Els Mansell, Valgarður Sigurðsson, Elitza Deltcheva, et al.
Cell stem cell (2020) Vol. 28, Iss. 2, pp. 241-256.e6
Open Access | Times Cited: 116
Neurodegeneration and Alzheimer's disease (AD). What Can Proteomics Tell Us About the Alzheimer's Brain?
Guillermo Moya‐Alvarado, Noga Gershoni‐Emek, Eran Perlson, et al.
Molecular & Cellular Proteomics (2016) Vol. 15, Iss. 2, pp. 409-425
Open Access | Times Cited: 106
Mitochondrial hyperpolarization in iPSC-derived neurons from patients of FTDP-17 with 10+16 MAPT mutation leads to oxidative stress and neurodegeneration
Noemí Esteras, Jonathan D. Rohrer, John Hardy, et al.
Redox Biology (2017) Vol. 12, pp. 410-422
Open Access | Times Cited: 104
Mitochondria- and Oxidative Stress-Targeting Substances in Cognitive Decline-Related Disorders: From Molecular Mechanisms to Clinical Evidence
Imane Lejri, Anastasia Agapouda, Amandine Grimm, et al.
Oxidative Medicine and Cellular Longevity (2019) Vol. 2019, pp. 1-26
Open Access | Times Cited: 97
Active Cellular and Subcellular Targeting of Nanoparticles for Drug Delivery
Okhil K. Nag, James B. Delehanty
Pharmaceutics (2019) Vol. 11, Iss. 10, pp. 543-543
Open Access | Times Cited: 86
The Multifaceted Regulation of Mitochondria in Ferroptosis
Hao Wu, Fengli Wang, Na Ta, et al.
Life (2021) Vol. 11, Iss. 3, pp. 222-222
Open Access | Times Cited: 86
Relationships between Mitochondrial Dysfunction and Neurotransmission Failure in Alzheimer’s Disease
K. Y. Wong, Jaydeep Roy, Man Lung Fung, et al.
Aging and Disease (2020) Vol. 11, Iss. 5, pp. 1291-1291
Open Access | Times Cited: 84
Alpha-Secretase ADAM10 Regulation: Insights into Alzheimer’s Disease Treatment
Rafaela Peron, Izabela Pereira Vatanabe, Patrícia Regina Manzine, et al.
Pharmaceuticals (2018) Vol. 11, Iss. 1, pp. 12-12
Open Access | Times Cited: 83
Protective role of IGF-1 and GLP-1 signaling activation in neurological dysfunctions
Sonalika Bhalla, Sidharth Mehan, Andleeb Khan, et al.
Neuroscience & Biobehavioral Reviews (2022) Vol. 142, pp. 104896-104896
Closed Access | Times Cited: 60
Page 1 - Next Page

Scroll to top